Intravesical Bacillus Calmette-Guerin Therapy for Superficial Bladder Cancer: Effect of Bacillus Calmette-Guerin Viability on Treatment Results-Reference-Cited by-同舟云学术

Intravesical Bacillus Calmette-Guerin Therapy for Superficial Bladder Cancer: Effect of Bacillus Calmette-Guerin Viability on Treatment Results

Published:1985-07 Issue:1 Volume:134 Page:48-53
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Kelley David R.¹,Ratliff Timothy L.¹,Catalona William J.¹,Shapiro Amos¹,Lage Janice M.¹,Bauer Walter C.¹,Haaff Eric O.¹,Dresner Steven M.¹

Affiliation:

1. From the Divisions of Urology and Surgical Pathology, Washington University School of Medicine and The Jewish Hospital of St. Louis, St. Louis, Missouri

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference18 articles.

1. Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors;Morales;J. Urol.,1976

2. Treatment of superficial bladder cancer with intravesical BCG;Camacho;Proc. Amer. Ass. Cancer Res. Amer. Soc. Clin. Oncol.,1980

3. Bladder cancer immunotherapy;Lamm;J. Urol.,1982

4. Experience with bacillus Calmette-Guerin in patients with superficial bladder carcinoma;Brosman;J. Urol.,1982

5. Prophylaxis of recurrent bladder cancer with bacillus Calmette-Guerin;Morales,1979

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Evolving Landscape of Bladder Tertiary Lymphoid Structures;Journal of Urology;2023-07

2. Novel intravesical bacterial immunotherapy induces rejection of BCG-unresponsive established bladder tumors;Journal for ImmunoTherapy of Cancer;2022-07

3. Bacillus Calmette-Guérin Retains Clinically Relevant Viability for up to 72 Hours After Reconstitution: Potential Implications for Clinical Practice in Times of Shortage;European Urology Oncology;2021-10

4. At a time of global BCG shortage, attempts at optimizing BCG dose and schedule is no longer the answer;Urologic Oncology: Seminars and Original Investigations;2021-02

5. Identification of Sex Differences in Tumor-Specific T Cell Infiltration in Bladder Tumor-Bearing Mice Treated with BCG Immunotherapy;Bladder Cancer;2020-12-14